Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Katzenstein

Showing results (131-140 of 162) with videos related to

Pageof 17
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|June 6, 2000
Efavirenz- and adefovir dipivoxil-based salvage therapy in highly treatment-experienced patients: clinical and genotypic predictors of virologic responseN S Shulman, A R Zolopa, D J Passaro, et al.
The New England Journal of Medicine|October 10, 1996
The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study TeamD A Katzenstein, S M Hammer, M D Hughes, et al.
AIDS Research and Human Retroviruses|March 11, 1990
Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infectionL A Sawyer, D A Katzenstein, R M Hendry, et al.
Scientific Reports|September 16, 2017
Evolution of gag and gp41 in Patients Receiving Ritonavir-Boosted Protease InhibitorsJusten Manasa, Vici Varghese, Sergei L Kosakovsky Pond, et al.
Journal of Virology|July 28, 2010
Genetic analyses of HIV-1 env sequences demonstrate limited compartmentalization in breast milk and suggest viral replication within the breast that increases with mastitisSoren Gantt, Jacquelyn Carlsson, Laura Heath, et al.
Open Forum Infectious Diseases|July 16, 2016
Global Comparison of Drug Resistance Mutations After First-Line Antiretroviral Therapy Across Human Immunodeficiency Virus-1 SubtypesAustin Huang, Joseph W Hogan, Xi Luo, et al.
Plos One|May 27, 2010
Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutationsAlberto Diaz de Leon, Jennifer T Cronkhite, Anna-Luise A Katzenstein, et al.
Journal of Virology|May 23, 2014
Association between latent proviral characteristics and immune activation in antiretrovirus-treated human immunodeficiency virus type 1-infected adultsEmily C Liang, Lindsay Sceats, Nicholas L Bayless, et al.
Antiviral Therapy|May 1, 2001
Meta-analysis of five randomized controlled trials comparing continuation of zidovudine versus switching to didanosine in HIV-infected individualsJ M Raboud, J S Montaner, S Rae, et al.
The New England Journal of Medicine|October 10, 1996
A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study TeamS M Hammer, D A Katzenstein, M D Hughes, et al.
Pageof 17

Showing results (131-140 of 162) with videos related to

Sort By:
Pageof 17
Journal of Acquired Immune Deficiency Syndromes (1999)|June 6, 2000
Efavirenz- and adefovir dipivoxil-based salvage therapy in highly treatment-experienced patients: clinical and genotypic predictors of virologic responseN S Shulman, A R Zolopa, D J Passaro, et al.
The New England Journal of Medicine|October 10, 1996
The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study TeamD A Katzenstein, S M Hammer, M D Hughes, et al.
AIDS Research and Human Retroviruses|March 11, 1990
Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infectionL A Sawyer, D A Katzenstein, R M Hendry, et al.
Scientific Reports|September 16, 2017
Evolution of gag and gp41 in Patients Receiving Ritonavir-Boosted Protease InhibitorsJusten Manasa, Vici Varghese, Sergei L Kosakovsky Pond, et al.
Journal of Virology|July 28, 2010
Genetic analyses of HIV-1 env sequences demonstrate limited compartmentalization in breast milk and suggest viral replication within the breast that increases with mastitisSoren Gantt, Jacquelyn Carlsson, Laura Heath, et al.
Open Forum Infectious Diseases|July 16, 2016
Global Comparison of Drug Resistance Mutations After First-Line Antiretroviral Therapy Across Human Immunodeficiency Virus-1 SubtypesAustin Huang, Joseph W Hogan, Xi Luo, et al.
Plos One|May 27, 2010
Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutationsAlberto Diaz de Leon, Jennifer T Cronkhite, Anna-Luise A Katzenstein, et al.
Journal of Virology|May 23, 2014
Association between latent proviral characteristics and immune activation in antiretrovirus-treated human immunodeficiency virus type 1-infected adultsEmily C Liang, Lindsay Sceats, Nicholas L Bayless, et al.
Antiviral Therapy|May 1, 2001
Meta-analysis of five randomized controlled trials comparing continuation of zidovudine versus switching to didanosine in HIV-infected individualsJ M Raboud, J S Montaner, S Rae, et al.
The New England Journal of Medicine|October 10, 1996
A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study TeamS M Hammer, D A Katzenstein, M D Hughes, et al.
Pageof 17